CLINICAL_TRIALS
trial_result
· 2020-10-08
Clinical Trial Update: A Study of IO103 in Montanide Adjuvant for Basal Cell Carcinoma [Phase 2]
Summary
A phase 2 trial evaluating IO103 with Montanide adjuvant for basal cell carcinoma has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Herlev and Gentofte Hospital | Conditions: Basal Cell Carcinoma | Phase 2 | Status: COMPLETED